Tabacum CA-NHP Not yet graded
CA licensed ingredient
Market presence64 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014212
Compound index — T
767 substances begin with T. 8 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 200 of them, Tabacum – Teprotumumab.
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
Tabanus CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014213
Tabanus Nigrovittatus US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Ant Venoms [CS]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014214
Tabanus obsoletus CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014215
Tabanus trigonus CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014216
Tabebuia avellanedae CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014217
Tabebuia heptaphylla CA-NHP Not yet graded
CA licensed ingredient
Market presence51 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014218
Tabebuia impetiginosa CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014219
Tabebuia Impetiginosa Bark US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]
Market presence21 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014220
tabelecleucel EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014221
Tabernaemontana divaricata CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014222
Table top sweeteners and foods beverages containing intense sweeteners EU-CLAIM Not yet graded
EU claims 0 authorised / 2 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “-intense sweeteners have no effect on carbohydrate metabolism, short or long-term blood glucose control or insulin secretion; -product [x] assists in blood glucose control.” | Non-authorised | Art.13(1) | EFSA opinion |
| “-intense sweetners help to maintain a healthy body weight; -intense sweetners help to control calorie intake.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-014223
Tabtoxin US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014224
Tacrine Hydrochloride US-DRUG Not yet graded
Earliest US approval1993
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014225
Tacrolimus EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedCalcineurin Inhibitor Immunosuppressant [EPC]; Calcineurin Inhibitors [MoA]; D11AH01; D11AX14
Earliest US approval1994
Market presence140 US product listings · 26 FDA applications · 5 EU medicines
Etalyn identifierETA-C-014226
Tadalafil EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedC02KX54; Endothelin Receptor Antagonist [EPC]; Endothelin Receptor Antagonists [MoA]; G04BE08
Earliest US approval2003
Market presence304 US product listings · 51 FDA applications · 6 EU medicines
Etalyn identifierETA-C-014227
Taenia Saginata US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Live; Live Human Adenovirus Type 4 Vaccine [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014228
Taenia Solium US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedActively Acquired Immunity [PE]; Adenovirus [Chemical/Ingredient]; Live; Live Human Adenovirus Type 4 Vaccine [EPC]
Market presence5 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014229
Tafasitamab-Cxix US-DRUG Not yet graded
Earliest US approval2020
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014232
Tafenoquine US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2018
Market presence5 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014233
Tafluprost US-DRUG Not yet graded
US: anda
Class as recordedIncreased Prostaglandin Activity [PE]; Prostaglandin Analog [EPC]; Prostaglandin Receptor Agonists [MoA]; Prostaglandins [CS]
Earliest US approval2012
Market presence13 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014234
Tagetes erecta CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
also: Tagetes erecta var. erecta, Tagetes ernstii H.Rob. & Nicolson
Market presence379 Canadian licensed products
Parts in scopeAerial parts; Lutein, (meso-zeaxanthin) and zeaxanthin extract in an oil suspension
Etalyn identifierETA-C-014236
Tagetes erecta L. CA-NHP Not yet graded
CA licensed ingredient
Market presence74 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014237
Tagetes tenuifolia Cav. EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeFlowers
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-014238
Tagraxofusp EU-MEDUS-DRUG Not yet graded
Tagraxofusp-Erzs US-DRUG Not yet graded
Earliest US approval2018
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014240
Taiwanofungus camphoratus CA-NHP Not yet graded
CA licensed ingredient
Market presence6 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014241
Taka-Diastase CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014242
Talazoparib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedL01XK04; Poly(ADP-Ribose) Polymerase Inhibitor [EPC]; Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
Earliest US approval2018
Market presence20 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-014243
Talcum CA-NHP Not yet graded
CA licensed ingredient
Market presence167 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014246
Taletrectinib US-DRUG Not yet graded
US: drug for further processing
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014247
Taletrectinib Adipate US-DRUG Not yet graded
US: bulk ingredient
Class as recordedKinase Inhibitor [EPC]; Proto-Oncogene Tyrosine-Protein Kinase ROS1 Inhibitors [MoA]
Earliest US approval2025
Market presence4 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014248
Taliglucerase Alfa EU-MEDUS-DRUG Not yet graded
EU medicine: RefusedUS: bla
Class as recordedA16AB11; Glucosylceramidase [CS]; Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC]
Earliest US approval2012
Market presence4 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-014249
Tallow US-DRUG Not yet graded
US: otc monograph drug
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014251
Tallow Acid, Beef US-DRUG Not yet graded
US: otc monograph drug
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014252
Talquetamab-Tgvs US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014254
Tamarindus indica CA-NHPEU-NOVEL Not yet graded
Tamarix chinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014256
Tamarix gallica CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014257
Tamarix Gallica Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence7 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014258
Tamarix Gallica Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014259
Tamoxifen Citrate US-DRUG Not yet graded
US: anda
Class as recordedEstrogen Agonist/Antagonist [EPC]; Selective Estrogen Receptor Modulators [MoA]
Earliest US approval1977
Market presence29 US product listings · 14 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014260
Tamsulosin Hydrochloride US-DRUG Not yet graded
US: anda
Class as recorded5-alpha Reductase Inhibitor [EPC]; 5-alpha Reductase Inhibitors [MoA]; Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
Earliest US approval1997
Market presence80 US product listings · 21 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014261
Tamus communis CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014262
Tanaceti parthenii herba EU-HERBUS-DRUG Not yet graded
Herbal monograph: C: ongoing call for scientific dataUS: unapproved drug other
also: Feverfew; Tanacetum parthenium (L.) Schultz Bip.
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence1 US product listings
Etalyn identifierETA-C-014263
Tanacetum Parthenium Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014265
Tanacetum vulgare CA-NHP Not yet graded
CA licensed ingredient
Market presence29 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014266
Tanacetum Vulgare TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Antimalarial [EPC]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014267
Tanacetum Vulgare Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014268
tanezumab EU-MED Not yet graded
EU medicine: Refused
Class as recordedN02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014269
Tangerine US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014270
Tangerine Peel US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014271
Tannic Acid US-DRUG Not yet graded
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014272
Tannicum acidum CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014273
Tantalum US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Allergens [CS]; Ascorbic Acid [CS]
Market presence17 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014274
Tantalum Carbide US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014275
Tapentadol US-CSAUS-DRUG Not yet graded
Tapinarof US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAryl Hydrocarbon Receptor Agonist [EPC]; Aryl Hydrocarbon Receptor Agonists [MoA]
Earliest US approval2022
Market presence7 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014277
Tarantula hispanica CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014278
Taraxaci folium EU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific data
also: Dandelion Leaf; Dandelion Root with Herb; Taraxaci radix cum herba; Taraxacum officinale Weber ex Wigg.
Class as recordedherbal: Loss of appetite;Urinary tract and genital disorders;Gastroi; herbal: Urinary tract and genital disorders
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-014279
Taraxaci officinalis radix CA-NHPEU-HERB Not yet graded
Herbal monograph: F: Assessment finalisedCA licensed ingredient
also: Dandelion root; Taraxacum officinale F.H. Wigg.
Class as recordedherbal: Loss of appetite;Urinary tract and genital disorders;Gastroi
Market presence1 Canadian licensed products
Etalyn identifierETA-C-014280
Taraxacum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014281
Taraxacum borealisinense CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014282
Taraxacum dens leonis CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014283
Taraxacum Mongolicum CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings · 152 Canadian licensed products
Etalyn identifierETA-C-014284
Taraxacum Officinale CA-NHPEU-NOVELUS-DRUG Not yet graded
Not novel in foodCA licensed ingredientUS: drug for further processing
also: Dandelion; Common dandelion; Chondrilla taraxacum (L.) Stokes
Class as recordedAcetylcholine Release Inhibitor [EPC]; Acetylcholine Release Inhibitors [MoA]; Acidifying Activity [MoA]; Actively Acquired Immunity [PE]
Market presence229 US product listings · 1,763 Canadian licensed products
Parts in scopeLeaves, flowers and roots
Etalyn identifierETA-C-014285
Taraxacum Officinale Flowering TOP US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014286
Taraxacum Officinale Leaf US-DRUG Not yet graded
US: otc monograph drug
Class as recordedDecreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014287
Taraxacum Officinale Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Animal Fur [CS]
Market presence14 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014288
Taraxacum officinale rh CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014289
Taraxacum Officinale Root US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014290
Taraxacum Officinale Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedCopper [CS]; Copper-containing Intrauterine Device [EPC]; Decreased Embryonic Implantation [PE]; Decreased Sperm Motility [PE]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014291
Taraxacum Palustre Root US-DRUG Not yet graded
US: unapproved drug other
Class as recordedAllergens [CS]; Allogeneic Cultured Cell Scaffold [EPC]; Calculi Dissolution Agent [EPC]; Cell-mediated Immunity [PE]
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014292
Taraxacum platycarpum CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014293
Taraxacum sinicum CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014294
Taraxacum Sinicum Whole US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014295
Taraxacum vulgare EU-NOVEL Not yet graded
Tarentula cubensis CA-NHP Not yet graded
CA licensed ingredient
Market presence9 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014297
Tarentula hispana CA-NHP Not yet graded
CA licensed ingredient
Market presence24 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014298
Tarentula hispanica CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014299
tarlatamab EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01FX33
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014300
Tarlatamab-Dlle US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014301
Tart cherry ETALYN B/supportedband 2
Recorded from — 0 of 7 registers
Etalyn identifierETA-C-014302
Tartaric Acid CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAcidifying Activity [MoA]; Allergens [CS]; Anti-coagulant [EPC]; Blood Coagulation Factor [EPC]
Earliest US approval1985
Market presence3 US product listings · 1 FDA applications · 4 Canadian licensed products
Etalyn identifierETA-C-014303
Tartaricum acidum CA-NHP Not yet graded
CA licensed ingredient
Market presence7 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014304
Tasimelteon EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedMelatonin Receptor Agonist [EPC]; Melatonin Receptor Agonists [MoA]; N05CH
Earliest US approval2014
Market presence14 US product listings · 5 FDA applications · 1 EU medicines
Etalyn identifierETA-C-014305
tasipimidine EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014306
tasonermin EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL03AX11
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014307
Taurine CA-NHPETALYNEU-CLAIMEU-MEDUS-DRUG B/supportedband 1
EU medicine: AuthorisedEU claims 0 authorised / 11 refusedCA licensed ingredientUS: anda
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Amino Acid [EPC]
Market presence24 US product listings · 1 EU medicines · 60 Canadian licensed products
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “- Helps to delay the onset of fatigue; - helps to maintain energy levels for prolonged periods during intense competition / exercise; - enhances endurance and helps to maintain peak effort during times of high physical demand.” | Non-authorised | Art.13(1) | EFSA opinion |
| “- Helps to protect body cells; - Helps to protect from radicals which cause cell oxidation; - Helps to protect cells and tissues from oxidation; - Contributes to the total antioxidant capacity of the body.” | Non-authorised | Art.13(1) | EFSA opinion |
| “- Possesses antioxidant and detoxifying properties; - can protect from free radical which cause cell damage, due to its antioxidant properties; - can protect cells and tissues from oxidative damages.” | Non-authorised | Art.13(1) | EFSA opinion |
| “- Supports the protection of the body's cells; - Supports the protection from free radicals; - Supports the protection of cells and tissues from oxidation.” | Non-authorised | Art.13(1) | EFSA opinion |
| “- Taurine is important for the energy metabolism; - the transformation of food into energy.” | Non-authorised | Art.13(1) | EFSA opinion |
| “-Helps physical and mental performance in cases of temporary stress” | Non-authorised | Art.13(1) | EFSA opinion |
| “Amino acid that plays an important role in the immune system.” | Non-authorised | Art.13(1) | EFSA opinion |
| “Helps to enhance tonus and vitality. Helps to support body's vitality. Helps to make you feel more energetic. Helps to improve physical well-being.” | Non-authorised | Art.13(1) | EFSA opinion |
| “It protects eye retina, for protection of liver cells from toxins, for proper heart function, proper cardio-vascular health” | Non-authorised | Art.13(1) | EFSA opinion |
| “It supports proper metabolism (uptake of glucose/caffeine).” | Non-authorised | Art.13(1) | EFSA opinion |
| “effet relaxant sur le coeur et les muscles” | Non-authorised | Art.13(1) | EFSA opinion |
Etalyn identifierETA-C-014308
Taurolidine US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAnti-coagulant [EPC]; Heparin [CS]; Unfractionated Heparin [EPC]
Earliest US approval2023
Market presence5 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014309
Tauroursodeoxycholic acid EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeWhole
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-014310
Taurursodiol US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval2022
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014311
Tavaborole US-DRUG Not yet graded
US: anda
Class as recordedBoron Compounds [CS]; Oxaborole Antifungal [EPC]; Protein Synthesis Inhibitors [MoA]
Earliest US approval2014
Market presence14 US product listings · 10 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014312
Taxillus chinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence135 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014313
Taxillus sutchuenensis CA-NHP Not yet graded
CA licensed ingredient
Market presence17 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014314
Taxodium Distichum Pollen US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]
Market presence23 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014315
Taxus baccata CA-NHP Not yet graded
CA licensed ingredient
Market presence4 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014316
Taxus Baccata Fruit US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014317
Taxus Baccata Whole US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014318
Tazarotene US-DRUG Not yet graded
US: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Retinoid [EPC]; Retinoids [CS]
Earliest US approval1997
Market presence32 US product listings · 16 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014319
Tazemetostat Hydrobromide US-DRUG Not yet graded
US: bulk ingredient
Class as recordedMethyltransferase Inhibitor [EPC]; Methyltransferase Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA]; Multidrug and Toxin Extrusion Transporter 2 K Inhibitors [MoA]
Earliest US approval2020
Market presence2 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014320
Tazobactam EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedCephalosporin Antibacterial [EPC]; Cephalosporins [CS]; J01DI54; Penicillin-class Antibacterial [EPC]
Earliest US approval1993
Market presence97 US product listings · 26 FDA applications · 1 EU medicines
Etalyn identifierETA-C-014321
TB-500 ETALYNUS-DRUG E/insufficientband 6
US: bulk ingredient
Market presence9 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014322
TBO-Filgrastim US-DRUG Not yet graded
Earliest US approval2012
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014323
TBSCT-FP US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014324
TEA Leaf US-DRUG Not yet graded
US: bla
Class as recordedAdrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Cell-mediated Immunity [PE]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014325
TEA Tree Oil US-DRUG Not yet graded
US: otc monograph drug
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Food Additives [CS]
Market presence26 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014326
TEA-Salicylate US-DRUG Not yet graded
US: unapproved drug other
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014327
Teanine EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “It heps relaz status without reducing the “alert status”; It hepls against nervous tension” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-014328
Tebentafusp EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedBispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC]; CD3 Receptor Agonists [MoA]; CD3-directed Antibody Interactions [MoA]; Glycoprotein 100 Peptide-Human Leukocyte Antigen-directed Antibody Interactions [MoA]
Market presence2 US product listings · 1 EU medicines
Etalyn identifierETA-C-014329
Tebentafusp-Tebn US-DRUG Not yet graded
Earliest US approval2022
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014330
Tebipenem Pivoxil Hydrobromide US-DRUG Not yet graded
Earliest US approval2026
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014331
Technetium TC-99M Albumin Aggregated KIT US-DRUG Not yet graded
Earliest US approval1976
Market presence3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014332
Technetium TC-99M Albumin Colloid KIT US-DRUG Not yet graded
Earliest US approval1983
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014333
Technetium TC-99M Apcitide US-DRUG Not yet graded
Earliest US approval1998
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014334
Technetium TC-99M Bicisate KIT US-DRUG Not yet graded
Earliest US approval1994
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014335
Technetium TC-99M Depreotide US-DRUG Not yet graded
Earliest US approval1999
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014336
Technetium TC-99M Disofenin KIT US-DRUG Not yet graded
Earliest US approval1982
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014337
Technetium TC-99M Etidronate KIT US-DRUG Not yet graded
Earliest US approval1973
Market presence4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014338
Technetium TC-99M Exametazime US-DRUG Not yet graded
US: nda
Class as recordedRadioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014339
Technetium TC-99M Exametazime KIT US-DRUG Not yet graded
Earliest US approval1988
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014340
Technetium TC-99M Ferpentetate KIT US-DRUG Not yet graded
Earliest US approval1974
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014341
Technetium TC-99M Gluceptate KIT US-DRUG Not yet graded
Earliest US approval1978
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014342
Technetium TC-99M Labeled Carbon US-DRUG Not yet graded
Earliest US approval2023
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014343
Technetium TC-99M Lidofenin KIT US-DRUG Not yet graded
Earliest US approval1986
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014344
Technetium TC-99M Mebrofenin KIT US-DRUG Not yet graded
Earliest US approval1987
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014345
Technetium TC-99M Medronate US-DRUG Not yet graded
US: drug for further processing
Class as recordedRadioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
Earliest US approval1978
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014346
Technetium TC-99M Medronate KIT US-DRUG Not yet graded
Earliest US approval1977
Market presence5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014347
Technetium TC-99M Mertiatide KIT US-DRUG Not yet graded
Earliest US approval1990
Market presence4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014348
Technetium TC-99M Oxidronate KIT US-DRUG Not yet graded
Earliest US approval1981
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014349
Technetium TC-99M Pentetate KIT US-DRUG Not yet graded
Earliest US approval1974
Market presence5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014350
Technetium TC-99M Polyphosphate KIT US-DRUG Not yet graded
Earliest US approval1976
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014351
Technetium TC-99M Pyro/trimeta Phosphates KIT US-DRUG Not yet graded
Earliest US approval1976
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014352
Technetium TC-99M Pyrophosphate US-DRUG Not yet graded
US: nda
Class as recordedRadioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014353
Technetium TC-99M Pyrophosphate KIT US-DRUG Not yet graded
Earliest US approval1974
Market presence3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014354
Technetium TC-99M Red Blood Cell KIT US-DRUG Not yet graded
Earliest US approval1991
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014355
Technetium TC-99M Sestamibi US-DRUG Not yet graded
US: anda
Class as recordedRadioactive Diagnostic Agent [EPC]; Radiopharmaceutical Activity [MoA]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014356
Technetium TC-99M Sestamibi KIT US-DRUG Not yet graded
Earliest US approval1990
Market presence5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014357
Technetium TC-99M Sodium Pertechnetate US-DRUG Not yet graded
US: nda
Earliest US approval1974
Market presence15 US product listings · 3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014358
Technetium TC-99M Sodium Pertechnetate Generator US-DRUG Not yet graded
Earliest US approval1973
Market presence5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014359
Technetium TC-99M Succimer US-DRUG Not yet graded
Earliest US approval2022
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014360
Technetium TC-99M Succimer KIT US-DRUG Not yet graded
Earliest US approval1982
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014361
Technetium TC-99M Sulfur Colloid US-DRUG Not yet graded
Earliest US approval1974
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014362
Technetium TC-99M Sulfur Colloid KIT US-DRUG Not yet graded
Earliest US approval1974
Market presence5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014363
Technetium TC-99M Teboroxime KIT US-DRUG Not yet graded
Earliest US approval1990
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014364
Technetium TC-99M Tetrofosmin KIT US-DRUG Not yet graded
Earliest US approval1996
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014365
Technetium TC-99M Tilmanocept US-DRUG Not yet graded
US: drug for further processing
Earliest US approval2013
Market presence1 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014366
Technetium TC99M Albumin Aggregated US-DRUG Not yet graded
Earliest US approval2020
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014367
Teclistamab-Cqyv US-DRUG Not yet graded
Earliest US approval2022
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014369
Tecovirimat EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C8 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]
Earliest US approval2018
Market presence6 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-014370
tedizolid EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; J01XX11; Oxazolidinone Antibacterial [EPC]; Oxazolidinones [CS]
Earliest US approval2014
Market presence6 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-014371
Teduglutide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedA16AX08; Analogs/Derivatives [Chemical/Ingredient]; GLP-2 Analog [EPC]; Glucagon-Like Peptide 2 [Chemical/Ingredient]
Earliest US approval2012
Market presence8 US product listings · 1 FDA applications · 2 EU medicines
Etalyn identifierETA-C-014372
Teestar™, a fenugreek seed extract standardised by its content of galactomannan EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Teestar™ lowers blood glucose levels” | Non-authorised | Art.13(5) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-014373
tegafur EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01BC53
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014374
Tegillarca granosa CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014376
tegomil fumarate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL04AX10
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014377
Tegoprazan US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014378
Telavancin EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, WithdrawnUS: bulk ingredient
Class as recordedJ01XA03; Lipoglycopeptide Antibacterial [EPC]; Lipoglycopeptides [EXT]
Earliest US approval2009
Market presence4 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-014380
Telisotuzumab Vedotin US-DRUG Not yet graded
US: bla
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014382
Telisotuzumab Vedotin-Tllv US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014383
Tellurium CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved drug other
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Bee Venoms [CS]
Market presence32 US product listings · 4 Canadian licensed products
Etalyn identifierETA-C-014385
Tellurium metallicum CA-NHP Not yet graded
CA licensed ingredient
Market presence14 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014386
Tellurium Tetrachloride US-DRUG Not yet graded
US: unapproved homeopathic
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014387
Telmisartan EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedAngiotensin 2 Receptor Antagonists [MoA]; Angiotensin 2 Receptor Blocker [EPC]; C09CA07; C09DA07
Earliest US approval1998
Market presence152 US product listings · 37 FDA applications · 15 EU medicines
Etalyn identifierETA-C-014388
Telomerase Reverse Transcriptase US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014389
Telotristat Ethyl US-DRUG Not yet graded
US: drug for further processing
Class as recordedTryptophan Hydroxylase Inhibitor [EPC]; Tryptophan Hydroxylase Inhibitors [MoA]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014390
Temazepam US-CSAUS-DRUG Not yet graded
temoporfin EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01XD05
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014393
Temozolomide EU-MEDUS-DRUG Not yet graded
Tenapanor US-DRUG Not yet graded
US: bulk ingredient
Class as recordedOrganic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]; Sodium-Hydrogen Exchanger 3 Inhibitor [EPC]; Sodium-Hydrogen Exchanger 3 Inhibitors [MoA]
Earliest US approval2019
Market presence11 US product listings · 2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014396
Tenecteplase EU-MEDUS-DRUG Not yet graded
Teneligliptin US-DRUG Not yet graded
US: bulk ingredient
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014398
Teniposide US-DRUG Not yet graded
Earliest US approval1992
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014399
Tenodera sinensis CA-NHP Not yet graded
CA licensed ingredient
Market presence20 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014400
Tenofovir US-DRUG Not yet graded
Earliest US approval2009
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014401
Tenofovir Alafenamide EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitor [EPC]
Earliest US approval2015
Market presence35 US product listings · 20 FDA applications · 5 EU medicines
Etalyn identifierETA-C-014402
Tenofovir Alafenamide Monofumarate US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014403
tenofovir disoproxil EU-MEDUS-DRUG Not yet graded
EU medicine: Authorised, WithdrawnUS: anda
Class as recordedBreast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inducers [MoA]
Earliest US approval2001
Market presence135 US product listings · 74 FDA applications · 6 EU medicines
Etalyn identifierETA-C-014404
tenogenic primed equine allogeneic peripheral blood-derived mesenchymal stem cells EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014405
Tenoxicam US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014406
Tephrosia purpurea CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-014407
Teplizumab-Mzwv US-DRUG Not yet graded
Earliest US approval2022
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-014409
Tepotinib Hydrochloride EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: nda
Class as recordedKinase Inhibitor [EPC]; L01EX21; Mesenchymal Epithelial Transition Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]
Earliest US approval2021
Market presence1 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-014410
tepoxalin EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQM01AE92
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-014411